Trials / Completed
CompletedNCT00036361
Broad Effectiveness: Study With Aripiprazole
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 444 (planned)
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to learn if aripiprazole is effective in the treatment of a large number of persons diagnosed with schizophrenia or schizoaffective disorders
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aripiprazole |
Timeline
- Start date
- 2002-07-01
- Primary completion
- 2003-01-01
- Completion
- 2003-01-01
- First posted
- 2002-05-10
- Last updated
- 2013-11-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00036361. Inclusion in this directory is not an endorsement.